Over the last decade, Singapore has established itself as the manufacturing hub for leading pharmaceutical companies in Asia. The country’s manufacturing output of pharmaceuticals and biological products grew at an impressive compounded annual growth rate (CAGR) of 15.8% over the 10-year period from 2001 to 2011. During the same period, the economic environment in Singapore had an average GDP growth rate of 6.3% per year.

The report includes the market trends and outlook of the pharmaceutical industry in Singapore. We examine the exports and imports of pharmaceutical products, key economic indicators, production index, value-added by sector, human resources, cost of operation, capital expenditure and government initiatives. Pharmaceutical sector contributed approximately 19.3% to the overall value added of the manufacturing industries. The sector only trailed electronic products sector in terms of value addition.

Also, the report encompasses the profile of leading players in the pharmaceutical industry as well as their respective financial highlights and SWOT analysis. Among the leading pharmaceutical players in Singapore are Luye Pharma Group Limited, Star Pharmaceuticals Limited and Pharmesis International Limited.

Key Points:

• The total output of pharmaceuticals and biological products in Singapore surged 20.1% year on year in 2011.

• Pharmaceutical sector contributed approximately 19.3% to the overall value added to manufacturing industries.

• At the end of the fourth quarter of FY2012, the pharmaceutical manufacturing index grew by a marginal rate of 1.1% year on year.